Patent Number: 8,815,939

Title: Substituted sulfamide derivatives

Abstract: The present invention is directed to novel substituted sulfamide derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives form in the treatment of anxiety and related disorders; bipolar depression and mania; depression; epilepsy and related disorders; epileptogenesis; glucose related disorders; lipid related disorders; migraine; obesity; pain; substance abuse and as neuroprotective agents. The present invention is further directed to a process for the preparation of the novel substituted sulfamide derivatives.

Inventors: McComsey; David F. (Warminster, PA), Parker; Michael H. (Chalfont, PA)

Assignee: Janssen Pharmaceutica NV

International Classification: A61K 31/357 (20060101); C07D 319/16 (20060101); A61P 25/22 (20060101)

Expiration Date: 8/26/12018